June 2, 2020
Takeda Pharmaceutical has earned the nod of a key European drug panel recommending approval of a pre-filled syringe version of its hereditary angioedema (HAE) treatment Takhzyro (lanadelumab), the company said on May 29. Takhzyro is currently approved in Europe as...read more